Demographic and clinical characteristics of COVID-19 mortality in Southern India-A single centre observational study
Keywords:Covid 19, mortality, comorbidities, SARS-CoV2, India.
Background: COVID-19 pandemic has spread worldwide with new variants of viruses and reinfections. As we have to live with COVID-19,
public health efforts should focus on preventing avoidable mortalities. The mortality with COVID 19 shows marked regional variation; hence
regional studies are needed. Objectives: Our study analyses the demographic and clinical characteristics of deceased COVID-19 patients, which
are critical for developing geographic-specific public health interventions to reduce mortality. Materials and methods: We conducted a
retrospective observational study from 1 April 2020 to 31 August 2021 in Kerala, India. We analysed 1201 death summaries of laboratoryconfirmed
COVID-19 deaths and included 1076 cases for the study. Results: Mean age of the deceased was 65.7 years (SD: 14 years). Of the
total deaths, 65.9% were males. The mean duration between the onset of symptoms to admission in our hospital was 4.9 days (SD 3.7 days, IQR
5 days). The most frequent presenting symptoms were breathlessness (68.2%) and fever (57.3%). 90.1% in the study group had at least one
comorbidity. Diabetes (53.5%) was the most common comorbidity, followed by hypertension (52.3%). Diabetes was also the most frequent
comorbidity reported in COVID-19 deaths among young (≤40 years), pregnant and vaccinated groups. Conclusion: The elderly, males and
patients with underlying comorbidities, especially diabetes, die disproportionately due to COVID-19. Health intervention strategies like
vaccination, promotion of healthy lifestyle to control comorbidities and awareness programmes for COVID appropriate behaviour should be
prioritised in these vulnerable populations.
How to Cite
Copyright (c) 2022 Manu Mathews, Kadeeja Beevi B, Surag M K, Farha Ahmed Payyanil Karlath, Binoo Divakaran, Balakrishnan Valliot, Sudeep K
This work is licensed under a Creative Commons Attribution 4.0 International License.